Sentinel Node Mapping in Gynecologic Cancers: A Comprehensive Review

Area of Science:

• Oncology
• Nuclear Medicine
• Surgical Pathology

Background:

• Gynecologic cancers are a significant cause of mortality in women globally.
• The sentinel lymph node (SLN) concept, initially for penile cancer, is now applied to various malignancies.
• SLN mapping is increasingly adopted for early-stage cervical and vulvar cancers due to its safety and efficacy.

Purpose of the Study:

• To review the latest evidence on nuclear medicine and other techniques for SLN status assessment in gynecologic neoplasms.
• To highlight the current applications and ongoing challenges of SLN mapping in gynecologic oncology.

Main Methods:

• Review of recent scientific literature on sentinel lymph node biopsy and mapping.
• Focus on nuclear medicine-based techniques and complementary methods.
• Analysis of data pertaining to early-stage cervical, vulvar, endometrial, ovarian, and vaginal cancers.

Main Results:

• Sentinel lymph node mapping demonstrates high detection rates and sensitivity in early-stage cervical and vulvar cancers.
• Nuclear medicine and other imaging modalities are crucial for accurate SLN identification.
• Evidence for SLN mapping in endometrial, ovarian, and vaginal cancers is still evolving.

Conclusions:

• Sentinel lymph node biopsy is a valuable tool in managing select gynecologic cancers, improving staging accuracy and potentially reducing morbidity.
• Further research is needed to establish standardized protocols and expand the application of SLN mapping to a broader range of gynecologic neoplasms, particularly endometrial, ovarian, and vaginal cancers.